Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 190 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia

 		HR+HER2- Advanced Breast Cancer Russian Federation

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

 		Heart Failure Phase 2 United States
Spain
Germany
Taiwan
Japan
Portugal
View All

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

 		Moderate-to-severe Plaque Psoriasis Russian Federation

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR

 		Giant Cell Arteritis, Polymyalgia Rheumatica Phase 1 United States

WOE of Anti-CD20 Therapies

 		Multiple Sclerosis United States

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

 		Coronary Heart Disease, Clonal Hematopoiesis of Indeterminate Potential (CHIP) Phase 2 Germany
Canada

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

 		Chronic Myeloid Leukemia France

A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China

 		Chronic Spontaneous Urticaria China

A Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo and With Omalizumab as Active Control in CSU Adult Patients.

 		Chronic Spontaneous Urticaria Phase 3 India
Brazil
Netherlands
Korea, Republic of
Turkey
Germany
Thailand
Spain
Slovakia
Czech Republic
Argentina
Canada
Poland
Switzerland
Malaysia
France
Australia
Italy
Bulgaria
Taiwan
View All

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease

 		Coronary Heart Disease Phase 2 United States